Yes. Aspirin is an anti-inflammatory drug, but dose matters. It blocks the platelet enzyme 150 to 200 times more strongly than the enzyme behind swelling and pain, so the daily low dose acts mainly on clotting. In small trials, low doses did not lower CRP, a common inflammation marker.
A very old drug with two jobs
People treated aches and swollen joints with willow bark long before anyone knew why it worked. The bark turned out to contain salicylates. In 1897 a chemist made a new form of salicylic acid, and it became aspirin, one of the most widely used medicines of all time.
Today aspirin has two jobs. At the doses on a pain reliever label, it eases headaches, swelling and fever. At a much smaller daily dose, many adults take it to lower their odds of a heart attack or stroke, because it keeps platelets from clumping. It is the same pill both times, and the dose decides which job it does.
Is aspirin anti-inflammatory?
Yes. In 1971 a scientist named John Vane showed how. Aspirin and the drugs like it (called NSAIDs, short for nonsteroidal anti-inflammatory drugs) block an enzyme now called cyclooxygenase, or COX. Without COX, the body makes fewer prostaglandins. Those are the chemical messengers that cause swelling, pain and fever.
Aspirin blocks the platelet enzyme about 150 to 200 times more strongly than the enzyme behind swelling.From a 1997 review in Semin Thromb Hemost
Twenty years later, scientists found that COX comes in two forms. COX-1 does everyday upkeep. It helps protect the stomach lining, keeps the kidneys working and lets platelets clump when you need to stop bleeding. COX-2 ramps up when there is inflammation, and its products cause many of the symptoms of arthritis.
That split explains both sides of aspirin. Blocking COX-2 calms inflammation. Blocking COX-1 is what thins the blood, and also what can upset the stomach.
Why the dose changes everything
Here is the key fact. Aspirin blocks COX-1 in platelets about 150 to 200 times more strongly than it blocks COX-2. A review of aspirin and platelets says that gap "explains the different dosage requirements" for aspirin as a clot blocker and as an anti-inflammatory.
Platelets are the tiny blood cells that start a clot. Aspirin shuts down their COX-1 for good, so a small dose goes a long way: 100 mg a day is enough to prevent clots in the heart's arteries. Reaching COX-2 takes much more.
The pain studies show the same pattern. A Cochrane review pooled 68 trials of a single dose of aspirin for pain after surgery. Doses of 600 or 650 mg, 900 or 1,000 mg, and 1,200 mg all worked better than a placebo, and the higher doses worked best. Lower doses did no better than a placebo.
Does daily low-dose aspirin reduce inflammation in the body?
Not in the way most people picture. CRP (C-reactive protein) is a protein your liver makes when there is inflammation, and it is the marker most doctors check.
In a 2000 randomized trial, 32 healthy young men took 81 or 325 mg of aspirin a day for 7 days. Their CRP did not change in a meaningful way, at rest or after a hard treadmill test. In a 2011 randomized trial of people with well-controlled high blood pressure, 100 mg a day for 3 months did not lower CRP either. The authors concluded that calming inflammation may not play a big part in how low-dose aspirin protects the heart in people like them.
The story has a twist, though. Aspirin also helps the body make "aspirin-triggered lipoxins," signals that help calm inflammation. In an 8-week randomized trial of 128 healthy adults, these signals rose with 81 mg a day, rose only slightly with 325 mg, and did not clearly change with 650 mg. So the smallest dose had the biggest effect on this one signal.
A small 2017 trial points the same way. Healthy volunteers took 75 or 1,200 mg of aspirin for 7 days, then inhaled a bacterial substance that inflames the lungs on purpose. Aspirin reduced lung inflammation cells and some damage markers, and the low and high doses worked about the same. It did not lower the main marker the study measured.
These were short tests in healthy people. They hint that low-dose aspirin does more than thin the blood, but they don't show a daily low dose lowering everyday inflammation.
The trade-off: bleeding
Blocking COX-1 has a cost at every dose. Any dose that works on platelets raises the risk of bleeding.
A 2019 meta-analysis pooled 13 trials with 164,225 people who did not have heart disease. Aspirin was linked to fewer heart attacks, strokes and heart deaths. It was also linked to more major bleeding: 23.1 bleeds per 10,000 people per year on aspirin, against 16.4 without it. An umbrella review of low-dose aspirin found strong evidence from trials for more major bleeding in the gut and inside the skull.
That balance is why advice changed. In 2022, the US Preventive Services Task Force recommended against starting low-dose aspirin to prevent a first heart attack or stroke in adults 60 or older. For adults 40 to 59 at higher heart risk, it called the choice an individual one with a small benefit. Heart experts now put more weight on safety than they once did.
What this means for you
Tick what you'll try this week. Your picks stay on this device.
you take a blood thinner or a daily aspirin, have had a stomach ulcer or bleeding, have kidney disease, have asthma that flares with pain relievers, are pregnant, are over 60 and thinking of starting daily aspirin, or want to give aspirin to a child or teenager.
One tap. Results appear once 50 readers have voted, and the count is always real.
The bottom line
Willow bark, a lab discovery in 1971, and an enzyme with two forms all lead to the same place. Aspirin is a real anti-inflammatory drug. But the little daily pill and the pain reliever dose are doing different jobs. The low dose is there to stop clots, and the trials we found did not show it lowering CRP. So if inflammation is your worry, the daily aspirin is not your tool. Ask what else might be.
Common questions
What is the anti-inflammatory dose of aspirin?
There is no single number in the research we checked, but it is far above the daily low dose. Aspirin blocks the inflammation enzyme 150 to 200 times less strongly than the platelet enzyme, so it needs higher doses. In pain trials, single doses from 600 to 1,200 mg worked, and lower doses did not beat a placebo. Follow the label, and ask a doctor about anything longer than short-term use.
Does aspirin reduce inflammation in the body?
At pain reliever doses, aspirin blocks the prostaglandins that cause swelling, pain and fever. At low daily doses, the picture is less clear. Small trials found no meaningful drop in CRP with 81 to 325 mg for a week or 100 mg for 3 months. But 81 mg a day did raise a calming signal called aspirin-triggered lipoxin.
Does aspirin reduce inflammation and pain?
Yes, at the right dose. Aspirin stops prostaglandins, which drive both swelling and pain. A Cochrane review of 68 trials found single doses of 600 mg or more eased pain after surgery, and higher doses worked best. Pain relief was very similar, milligram for milligram, to acetaminophen (also called paracetamol). Higher doses brought more side effects.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 11 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked October 31, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- ReviewAspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.Schrör K Semin Thromb Hemost, 1997.PubMedFull paper
- Meta-analysisSingle dose oral aspirin for acute postoperative pain in adults.Derry S, Moore RA Cochrane Database Syst Rev, 2012.PubMedFull paper
- Randomized trialEffect of short-term aspirin use on C-reactive protein.Feng D, Tracy RP, Lipinska I et al. J Thromb Thrombolysis, 2000.PubMedFull paper
- Randomized trialThe effect of aspirin on C-reactive protein in hypertensive patients.Kim MA, Kim CJ, Seo JB et al. Clin Exp Hypertens, 2011.PubMedFull paper
- Randomized trialAspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.Chiang N, Bermudez EA, Ridker PM et al. Proc Natl Acad Sci U S A, 2004.PubMedFull paper
- Randomized trialAspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS.Hamid U, Krasnodembskaya A, Fitzgerald M et al. Thorax, 2017.PubMedFull paper
- Umbrella reviewEffect of low-dose aspirin on health outcomes: An umbrella review of systematic reviews and meta-analyses.Veronese N, Demurtas J, Thompson T et al. Br J Clin Pharmacol, 2020.PubMedFull paper
- Meta-analysisAssociation of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.Zheng SL, Roddick AJ JAMA, 2019.PubMedFull paper
- GuidelineAspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.Davidson KW, Barry MJ, Mangione CM et al. JAMA, 2022.PubMedFull paper
- ReviewLow-dose aspirin for the prevention of atherosclerotic cardiovascular disease.Patrono C Eur Heart J, 2024.PubMedFull paper
